Identification of Gln-Apremilast:
No description |
Search images on Google Product Monograph
Active Ingredients:
- apremilast, 30 MG
DIN: 02518910
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AA - Selective immunosuppressants (ATC, WHO)
- L04AA32 - APREMILAST (WHO)
Pharmaceutical standard: MFR